Consensus Guidelines for Evaluating and Treating Patients with Upper Gastrointestinal Symptoms in the Primary Care Setting

1998 ◽  
Vol 14 (Supplement 2) ◽  
pp. 5-10 ◽  
Author(s):  
Mark J. Whitaker
2017 ◽  
Vol 57 (9) ◽  
pp. 1058-1063 ◽  
Author(s):  
Ramya Ramraj ◽  
Amy Garcia ◽  
David Mosen ◽  
Lisa Waiwaiole ◽  
Ning Smith

Fecal calprotectin (FC) is a marker of intestinal inflammation. Data are limited on utility of routine FC testing in pediatric primary care. Participants 0 to 18 years old who had an FC test in the years 2010-2014 were retrospectively identified. Those with less than a year of follow-up or a prior diagnosis of inflammatory bowel disease (IBD) were excluded. In all, 84% (689/822) had normal FC; no participant with normal FC was diagnosed with IBD in the subsequent 12 months. Also, 16% (133/822) had elevated FC, and 31% of those (42/133) were diagnosed with IBD. FC values for IBD and non-IBD groups were 1084 µg/g (interquartile range [IQR] = 514.4-2000) and 27.05 µg/g (IQR = 15.6-62.6; P < .001), respectively. Abdominal pain was the primary indication. In this cohort, sensitivity of FC for IBD is 100%, and specificity is 88%. The FC test can be an excellent tool in the primary care setting to exclude IBD and avoid unnecessary referrals and colonoscopies.


2007 ◽  
Vol 177 (4S) ◽  
pp. 494-495 ◽  
Author(s):  
Michael Naslund ◽  
Alicia Gilsenan ◽  
Kirk Midkiff ◽  
Eric Wolford ◽  
Aileen Bown ◽  
...  

2008 ◽  
Author(s):  
Ruth Elaine Graves ◽  
Tanya N. Alim ◽  
Notalelomwan Aigbogun ◽  
Thomas A. Mellman ◽  
William B. Lawson

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1306-P
Author(s):  
DANIELLE S. MEDEIROS ◽  
LORENA S. ROSA ◽  
SOSTENES MISTRO ◽  
CLAVDIA N. KOCHERGIN ◽  
DANIELA A. SOARES ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document